This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Törnwall, M. E. Articles by Huttunen, J. K. Search for Related Content PubMed PubMed Citation Articles by Törnwall, M. E. Articles by Huttunen, J. K.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3475-3480.)
© 1997 American Heart Association, Inc.

Articles

Effect of -Tocopherol (Vitamin E) and ß-Carotene Supplementation on the Incidence of Intermittent Claudication in Male Smokers

Markareetta E. Törnwall; Jarmo Virtamo; Jari K. Haukka; Antti Aro; Demetrius Albanes; Brenda K. Edwards; ; Jussi K. Huttunen

From the National Public Health Institute, Helsinki, Finland (M.E.T., J.V., J.K. Haukka, A.A., J.K. Huttunen), and the National Cancer Institute, Bethesda, Md (D.A., B.K.E.).

Correspondence to Dr Markareetta Törnwall, ATBC Study, Department of Nutrition, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland. E-mail markareetta.tornwall{at}ktl.fi

Abstract We examined the primary preventive effect of vitamin E (-tocopherol) and ß-carotene supplementation on intermittent claudication. The subjects—participants in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study—were male smokers aged 50 to 69 years who were randomly assigned to receive 50 mg of -tocopherol daily, 20 mg of ß-carotene daily, both, or placebo. At baseline, there were 26 289 men with no history or symptoms of intermittent claudication. The Rose questionnaire on intermittent claudication was administered annually to discover incident cases. We observed 2704 cases of first occurrence of typical intermittent claudication during a median follow-up time of 4.0 years. Compared with placebo, the adjusted relative risk for typical intermittent claudication among those who received -tocopherol only was 1.11 (95% confidence interval, 1.00-1.24); among those who received -tocopherol and ß-carotene, 1.02 (0.91-1.13); and among those who received ß-carotene only, 1.02 (0.92-1.14). When we compared the -tocopherol–supplemented subjects with those who received no -tocopherol, the adjusted relative risk for typical intermittent claudication was 1.05 (0.98-1.14), and for ß-carotene–supplemented subjects compared with those who did not receive ß-carotene, the relative risk was 0.96 (0.89-1.04). In conclusion, no primary preventive effect on intermittent claudication was observed among middle-aged male smokers who were supplemented with -tocopherol, ß-carotene, or both.

Key Words: intermittent claudication • prevention • vitamin E • -tocopherol • antioxidants

This article has been cited by other articles:

				P. R. Trumbo The Level of Evidence for Permitting a Qualified Health Claim: FDA's Review of the Evidence for Selenium and Cancer and Vitamin E and Heart Disease J. Nutr., February 1, 2005; 135(2): 354 - 356. [Abstract] [Full Text] [PDF]